Whoa whoa whoa rgc!
Correct me if I'm wrong skorpian but my understanding is Oncosil was Neurodiscovery, a company that acquired the BrachySil technology from pSivida which had the technology on hold because they were focused on eye drugs. That is why there was no application in 2009 IMO.
The capital raising may come when CE mark is given as the market will see that the company can sell its product into huge markets and it will be rerated. Doing a capital raising then won't anger shareholders, even Sirtex may become a cornerstone investor (ok I'm reaching with that one
Sales to overseas markets, page-20
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.18M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 675645 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 5541905 | 5 |
View Market Depth
| Last trade - 10.58am 24/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |
Day chart unavailable